Immediate Unselected Coronary Angiography Versus Delayed Triage in Survivors of Out-of-hospital Cardiac Arrest Without ST-segment Elevation (TOMAHAWK)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02750462 |
|
Recruitment Status :
Completed
First Posted : April 25, 2016
Last Update Posted : October 4, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of the trial is to compare immediate angiography in survivors of out of hospital cardiac arrest (OHCA) without ST-segment elevation versus delayed/selective catheterization with respect to 30 day mortality.
The TOMAHAWK trial is supported by the Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK).
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Out-of-hospital Cardiac Arrest | Other: Immediate coronary angiography Other: Delayed/selective coronary angiography | Phase 4 |
After inclusion and exclusion criteria have been checked patients will be randomized:
Group 1: Immediate angiography Patients randomized to group 1 will be transported to the catheterization laboratory as soon as possible after hospital admission for evaluation of coronary anatomy.
Group 2: Delayed/selective angiography Upon hospital admission, patients assigned to group 2 will first be transported to the ICU for further evaluation and stratification of OHCA etiology. Further triage will depend on the results of clinical examination and objective testing and will be left to the individual physician according to clinical judgment. Depending on clinical circumstances, further management may comprise medical therapy, laboratory testing, imaging such as echocardiography and/or computed tomography, hemodynamic or neurological monitoring, the initiation of therapeutic hypothermia or other measures of intensive care. If a high likelihood of an acute coronary trigger for OHCA persists (i.e. inconclusive results from clinical evaluation with ongoing suspicion of an acute coronary event, etc.), the treating physician may proceed to coronary angiography after a delay of 24h after the onset of cardiac arrest.
Vital status will be assessed at 30 days, 6 and 12 months after randomization by direct questioning if the patient is still hospitalized or structured telephone interview. Clinical events will be verified by original source data. At 6 and 12 months, quality of life will be assessed by the the Euroqol 5D questionnaire.
The TOMAHAWK trial is supported by the Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK).
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 558 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Immediate Unselected Coronary Angiography Versus Delayed Triage in Survivors of Out-of-hospital Cardiac Arrest Without ST-segment Elevation |
| Actual Study Start Date : | November 2016 |
| Actual Primary Completion Date : | September 2019 |
| Actual Study Completion Date : | September 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Immediate coronary angiography
Immediate coronary angiography in survivors of out-of-hospital cardiac arrest without ST-segment elevation
|
Other: Immediate coronary angiography
Immediate coronary angiography in survivors of out-of-hospital cardiac arrest without ST-segment elevation |
|
Active Comparator: Delayed/selective coronary angiography
Initial intensive care evaluation to further stratify the etiology of out-of-hospital cardiac arrest with delayed/selective coronary angiography if indicated
|
Other: Delayed/selective coronary angiography
Initial intensive care evaluation to further stratify the etiology of out-of-hospital cardiac arrest with delayed/selective coronary angiography if indicated |
- All-cause mortality [ Time Frame: 30 days ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 30 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Documented resuscitated OHCA of possible cardiac origin and return of spontaneous circulation
- Age ≥30 years
- Informed consent
Exclusion Criteria:
- ST-segment elevation or new left bundle branch block
- No return of spontaneous circulation upon hospital admission
- Severe hemodynamic or electrical instability requiring immediate coronary angiography/intervention (delay clinically not acceptable)
- Obvious extra-cardiac etiology such as traumatic brain injury, primary metabolic or electrolyte disorders, intoxication, overt hemorrhage, respiratory failure due to known lung disease, suffocation, drowning
- In-hospital cardiac arrest
- Known or likely pregnancy
- Participation in another intervention study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02750462
| Germany | |
| Universitäres Herzzentrum Lübeck | |
| Lübeck, Schleswig-Holstein, Germany, 23538 | |
| Responsible Party: | Steffen Desch, Associate director, University Hospital Schleswig-Holstein |
| ClinicalTrials.gov Identifier: | NCT02750462 |
| Other Study ID Numbers: |
TOMAHAWK2.0 |
| First Posted: | April 25, 2016 Key Record Dates |
| Last Update Posted: | October 4, 2019 |
| Last Verified: | October 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Heart Arrest Out-of-Hospital Cardiac Arrest Heart Diseases Cardiovascular Diseases |